

Publisher: John Wiley & Sons Inc
E-ISSN: 1346-8138|25|11|703-705
ISSN: 0385-2407
Source: THE JOURNAL OF DERMATOLOGY, Vol.25, Iss.11, 1998-11, pp. : 703-705
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
AbstractA randomized open study was undertaken to compare the therapeutic effects between low‐dose etretinate alone and low‐dose etretinate combined with eicosapentaenoic acid in 40 patients with chronic, stable psoriasis vulgaris. Better and more rapid improvement was obtained with the combination therapy for 12 weeks than with low‐dose etretinate monotherapy. Eicosapentaenoic acid was safe, and adverse reactions due to low‐dose etretinate were mild or tolerable. The combination regimen, therefore, has a satisfactory effect on psoriasis without marked adverse reactions.
Related content




Intervirology, Vol. 50, Iss. 6, 2008-02 ,pp. :


By Childers Martin K. Borenstein David Brown Richard L. Gershon Steven Hale Martin E. Petri Michelle Wan George J. Laudadio Charles Harrison Diane D.
Current Medical Research and Opinion, Vol. 21, Iss. 9, 2005-09 ,pp. :

